SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Burnham who wrote (3310)11/22/2000 8:37:58 PM
From: Bo Didley   of 5582
 
Yes, gumminvestors.com

is a great site to learn the basics.

Getting excited for the Nicotine Gum roll out
by the Joint Venture of GUMM with Swedish Match.
(Should be occuring in about two or so months)
Swedish Match distribution is 140 countries.

No one knows hardly anything about the JV except
that nicotine gum is a significant revenue generator
for SBH and PNU. Be sure to read about Nicotine Gum
at the web site: gumminvestors.com

Earlier in the year when WPI (Watson Pharma) announced they were
going to sell nicotine gum just in the USA, they're stock
exploded $10 points in a few days. This is a significant product and deserves thorough research.

From Nicotine GUMM alone, GUMM will make profit on both
manufacturing the gum and will make an additional 49% of the profits from the Joint Venture itself.
The upfront money for the JV is all coming from Swedish Match. GUMM is providing the intellectual know how.

Revenue growth from Nicotine gum around the world will be significant beyond current measure. Then add to that Zicam revenue growth. What an investment and forward looking bullishness these markets represent.

bo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext